“…The results are consistent with the views of stakeholders in the US and Australia that suggest pharmacists be involved in T&CM pharmaceutical care, and that such a role remains poorly defined. [28,32] This study reinforced the findings of earlier work in the US and Australia that also suggested pharmacists should at least assume a role in assuring the safe use of HMs [28,32]. Our findings suggest that barriers exist within a range of pharmacy sectors including government, professional associations, education, pharmacy business, pharmacist and research.…”